×
Levetiracetam in the Treatment of Acute Mania: An Open Add-On Study With an On-Off-On Design PDF
$ 40.00
Levetiracetam in the Treatment of Acute Mania: An Open Add-On Study With an On-Off-On Design PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder PDF
$ 40.00
A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder PDF quantity
$ 40.00
×
Psychological Impact of the COVID-19 Pandemic and Associated Lockdown on Outpatients With Psychiatric Illness: A Cross-Sectional Study PDF
$ 40.00
Psychological Impact of the COVID-19 Pandemic and Associated Lockdown on Outpatients With Psychiatric Illness: A Cross-Sectional Study PDF quantity
$ 40.00
×
Absence of Changes in Antidiuretic Hormone, Angiotensin II, and Atrial Natriuretic Peptide With Clozapine Treatment of Polydipsia-Hyponatremia: 2 Case Reports PDF
$ 40.00
Absence of Changes in Antidiuretic Hormone, Angiotensin II, and Atrial Natriuretic Peptide With Clozapine Treatment of Polydipsia-Hyponatremia: 2 Case Reports PDF quantity
$ 40.00
×
Retrospective Audit of the Management of Anal Insertion of Foreign Bodies: A Holistic Approach PDF
$ 40.00
Retrospective Audit of the Management of Anal Insertion of Foreign Bodies: A Holistic Approach PDF quantity
$ 40.00
×
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
×
Safety and Efficacy of Levetiracetam for Patients With Panic Disorder: Results of an Open-Label, Fixed-Flexible Dose Study PDF
$ 40.00
Safety and Efficacy of Levetiracetam for Patients With Panic Disorder: Results of an Open-Label, Fixed-Flexible Dose Study PDF quantity
$ 40.00
×
Exacerbation of Depression Symptoms in the Presence of Dermatitis Herpetiformis Rash, Celiac Disease, and Low Cholesterol PDF
$ 40.00
Exacerbation of Depression Symptoms in the Presence of Dermatitis Herpetiformis Rash, Celiac Disease, and Low Cholesterol PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
×
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF
$ 40.00
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF quantity
$ 40.00
×
The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone PDF
$ 40.00
The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
